DENTSPLY SIRONA (XRAY) CEO gets RSU dividend shares on Form 4 report

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. executive Daniel T. Scavilla, the company’s President, CEO and a director, reported acquiring additional common stock through equity compensation. On January 9, 2026, he received 245.816 shares of common stock at $0 per share, recorded as an acquisition. After this transaction, he directly beneficially owned 17,944.546 common shares.

According to the footnote, these shares represent dividends on restricted stock units (RSUs) paid in the form of additional RSUs, which follow the same vesting schedule as the underlying awards. The dividend RSUs vest at the same time as the related RSUs, and each RSU will convert into one share of DENTSPLY SIRONA common stock.

Insider Trade Summary

Net Buyer: 245.816 shares

Net Buy 1 txn

Insider Scavilla Daniel T

Role President, CEO & Member of BOD

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	245.816	$0.00	$0.00

Holdings After Transaction: Common Stock — 17,944.546 shares (Direct)

Footnotes (1)

1. F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Daniel T. Scavilla?

Daniel T. Scavilla, President, CEO and director of DENTSPLY SIRONA Inc., reported acquiring 245.816 shares of common stock on January 9, 2026 in a Form 4 filing.

At what price were the DENTSPLY SIRONA (XRAY) shares acquired in this Form 4?

The 245.816 common shares reported for Daniel T. Scavilla were acquired at a stated price of $0 per share, reflecting an equity compensation-related transaction.

How many DENTSPLY SIRONA (XRAY) shares does Daniel T. Scavilla own after this transaction?

Following the reported transaction, Daniel T. Scavilla directly beneficially owns 17,944.546 shares of DENTSPLY SIRONA common stock.

What is the nature of the RSU dividend shares reported for DENTSPLY SIRONA (XRAY)?

The transaction represents dividends on restricted stock units (RSUs) granted as additional RSUs. These dividend RSUs share the same vesting terms as the underlying RSU awards, and each RSU converts to one share of common stock.

Is Daniel T. Scavilla a director or officer of DENTSPLY SIRONA (XRAY)?

Yes. The Form 4 identifies Daniel T. Scavilla as a Director and as an Officer with the title President, CEO & Member of BOD of DENTSPLY SIRONA Inc.

Was the DENTSPLY SIRONA (XRAY) Form 4 filing made for one reporting person or a group?

The filing indicates it is a Form filed by one reporting person, covering the holdings and transaction of Daniel T. Scavilla alone.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/13/2026 - 04:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scavilla Daniel T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO & Member of BOD

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		245.816(1)	A	$0	17,944.546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.